Epidiolex: First FDA-approved drug made from cannabis component (CBD)

In a historic move, the U.S. Food and Drug Administration (FDA) recently approved Epidiolex — an epilepsy medication made fro ...Read more

Cannabidiol (CBD) oil and product FAQs: Fad or effective? Legal or not?

Trending: Cannabidiol (CBD) oil, gummies, tinctures and more. Why are cannabis products gaining popularity as medical treat ...Read more

Women’s Health Week: Ginny reflects on motherhood and “the perfect storm” of epilepsy and mental health conditions

In honor of National Women’s Health Week, Team of Advisors member Ginny ( Mrslinkgetter ) shares what it’s like to live with ...Read more

Meet Ginny from the PatientsLikeMe Team of Advisors

Say hello to Ginny ( Mrslinkgetter ), a case manager and family partner with Youth Mobile Crisis Intervention living with dep ...Read more

In her own words: Letitia shares about her new brain for Epilepsy Awareness Month

Have you met Letitia ( Letitia81 ) from the epilepsy community? Four years ago, her research on PatientsLikeMe led her to the ...Read more

PatientsLikeMe Welcomes Next Patient Team of Advisors

CAMBRIDGE, Mass, November 14, 2016 -- PatientsLikeMe has named 11 members to its patients-only 2016 - 2017 Team of Advisor ...Read more

“I am working on all of it slowly” — Member David opens up about his experience with PTS

Meet member David ( david61060 ), a United States Air Force veteran who’s living with multiple conditions including PTS, slee ...Read more

Your data doing good: The POEM Study

When you share your health data, we all learn Every minute of every day, people are sharing their health data on Patien ...Read more

Epilepsy Awareness Month: The value in helping others

It’s November, which means it’s Epilepsy Awareness Month . During our #NotAlone campaign , we shared how PatientsLikeMe mem ...Read more

Recapping with our Team of Advisors!

Many of you will remember meeting our inaugural Team of Advisors from when we first shared about this exciting team last ye ...Read more
